FRI097 A Case Of Evolocumab-induced Transaminitis Revealing A Gastrointestinal Melanoma

Disclosure: C. Nava Suarez: None. J.V. Mayrin: None. J. Prater: None. W. Jiang: None. Introduction: Proprotein convertase subtilisin/Kexin type 9 (PCSK-9) inhibitors, like evolocumab, are anti-lipid drugs with potent lipid-lowering effect, potential cardiovascular benefits, and good tolerability. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nava Suarez, Corina, Mayrin, Jane V, Prater, Janna, Jiang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555206/
http://dx.doi.org/10.1210/jendso/bvad114.611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555206/
http://dx.doi.org/10.1210/jendso/bvad114.611

Ejemplares similares